HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D W Fry Selected Research

Therapeutics

10/2001Anticancer therapy targeting the erbB family of receptor tyrosine kinases.
2/2000Site-directed irreversible inhibitors of the erbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D W Fry Research Topics

Disease

6Neoplasms (Cancer)
10/2001 - 01/2000
1Disease Progression
10/2001
1Breast Neoplasms (Breast Cancer)
10/2001
1Chills
10/2001
1Fever (Fevers)
10/2001
1Heart Failure
10/2001
1Hypersensitivity (Allergy)
10/2001
1Adenoma (Adenomas)
09/2000
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2000

Drug/Important Bio-Agent (IBA)

4Phosphotransferases (Kinase)IBA
10/2001 - 01/2000
4ErbB Receptors (EGF Receptor)IBA
10/2001 - 01/2000
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2001 - 01/2000
2tyrosine receptor (receptor, tyrosine)IBA
10/2001 - 02/2000
2Canertinib (CI 1033)IBA
10/2001 - 05/2001
2Tyrosine (L-Tyrosine)FDA Link
09/2000 - 01/2000
1Trastuzumab (Herceptin)FDA Link
10/2001
1Monoclonal AntibodiesIBA
10/2001
1Cyclin DIBA
05/2001
1Cyclin-Dependent Kinase Inhibitor p16IBA
05/2001
1ErbB-2 ReceptorIBA
05/2001
1GemcitabineFDA Link
05/2001
1Peptides (Polypeptides)IBA
09/2000
1Trefoil Factor-3IBA
09/2000
1Biological ProductsIBA
02/2000
1LigandsIBA
02/2000
1PD 0169414IBA
01/2000
1Therapeutic UsesIBA
01/2000
1Tyrosine Kinase InhibitorsIBA
01/2000

Therapy/Procedure

2Drug Therapy (Chemotherapy)
10/2001 - 02/2000
2Therapeutics
10/2001 - 02/2000
1Oral Administration
01/2000